- Home
- DXCM vs PHG Comparison
DXCM vs PHG Comparison
Compare DXCM & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- PHG
- Stock Information
- Founded
- DXCM 1999
- PHG 1891
- Country
- DXCM United States
- PHG Netherlands
- Employees
- DXCM N/A
- PHG N/A
- Industry
- DXCM Medical/Dental Instruments
- PHG Medical Electronics
- Sector
- DXCM Health Care
- PHG Health Care
- Exchange
- DXCM Nasdaq
- PHG Nasdaq
- Market Cap
- DXCM 31.7B
- PHG 26.0B
- IPO Year
- DXCM 2005
- PHG N/A
- Fundamental
- Price
- DXCM $60.73
- PHG $28.23
- Analyst Decision
- DXCM Strong Buy
- PHG Buy
- Analyst Count
- DXCM 20
- PHG 2
- Target Price
- DXCM $90.00
- PHG N/A
- AVG Volume (30 Days)
- DXCM 6.2M
- PHG 839.0K
- Earning Date
- DXCM 10-30-2025
- PHG 11-04-2025
- Dividend Yield
- DXCM N/A
- PHG 3.02%
- EPS Growth
- DXCM 7.75
- PHG N/A
- EPS
- DXCM 1.80
- PHG 0.20
- Revenue
- DXCM $4,515,900,000.00
- PHG $20,968,878,450.00
- Revenue This Year
- DXCM $17.43
- PHG $0.78
- Revenue Next Year
- DXCM $13.22
- PHG $3.16
- P/E Ratio
- DXCM $33.63
- PHG $136.59
- Revenue Growth
- DXCM 14.21
- PHG N/A
- 52 Week Low
- DXCM $56.45
- PHG $21.48
- 52 Week High
- DXCM $93.25
- PHG $29.29
- Technical
- Relative Strength Index (RSI)
- DXCM 33.07
- PHG 53.93
- Support Level
- DXCM $56.45
- PHG $27.04
- Resistance Level
- DXCM $69.17
- PHG $29.29
- Average True Range (ATR)
- DXCM 2.10
- PHG 0.55
- MACD
- DXCM -0.73
- PHG -0.10
- Stochastic Oscillator
- DXCM 27.43
- PHG 66.56
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About PHG Koninklijke Philips N.V. NY Registry Shares
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.